2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Term ID

CHEBI:144080

Synonyms

(PEtn-Man)3-GlcN-(acyl)PI zwitterion
2-acyl-6-[6-PEtn-alpha-D-Man(1->2)-6-PEtn-alpha-D-Man(1->6)-2-PEtn-alpha-D-Man(1->4)-alpha-D-GlcN]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion
a 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol
glycosylphosphatidylinositol H8 zwitterion
H8 GPI zwitterion

Definition

A phosphoethanolamine-glycosyl-phosphatidylinositol where R1 can be an alkyl or an acyl group, R2 and R3 are both acyl groups of undefined composition.

References

PMID:15632136

Ontology

ChEBI ( EBI )

Relationships

is a type of: organic molecular entity phosphoethanolamine-glycosyl-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion

organic molecular entity phosphoethanolamine-glycosyl-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion Show first 5 Terms
has_functional_parent: 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion Show first 5 Terms
inverse has_functional_parent: 2-acyl-6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue

2-acyl-6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue Show first 5 Terms

Phenotype

Phenotype resulting from 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Phenotype where environments contain 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Phenotype modified by environments containing 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Phenotype affecting 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-6-phosphoethanolamine-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

Human Disease Model